Loading...

Abiomed, Inc.

ABMD•NASDAQ
Healthcare
Medical - Devices
$381.02
$0.00(0.00%)

Abiomed, Inc. (ABMD) Stock Overview

Explore Abiomed, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 66.9/100

Key Financials

Market Cap17.2B
P/E Ratio126.85
EPS (TTM)$5.83
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$262.82

ABMD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Abiomed, Inc. (ABMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $262.82.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 126.85 and a market capitalization of 17.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;